Gilead says 'criminal enterprise' sold counterfeit versions of its HIV drugs - WSJ
Justin Sullivan/Getty Images News


Gilead Sciences (GILD
-1.8%) says that a "complex and criminal enterprise" was distributing counterfeit versions of its HIV drugs through the U.S. supply chain, The Wall Street Journal reports.
A Gilead spokesman said that the racket has been stopped.

The newspaper says that the company identified 85,247 counterfeit bottles of its medicines valued at more than $250M. The drugs were sold to pharmacies over the last two years.
The scheme was uncovered through an investigation and court-approved civil seizures, a company spokesman said.
Gilead considers medications as counterfeit if the drugs themselves are fake or they are genuine but have altered packaging or doctored documentation.
The company said some of the medications were bought from homeless or drug-addicted HIV patients and then resold using altered documentation.
In July, Gilead filed a lawsuit against "dozens" of pharmaceutical suppliers and distributors. The case was sealed until today.
The Journal reports that Gilead hired private investigators and worked with law enforcement to conduct seizures of offices and warehouses, before the defendants were aware of the case.
In August, Gilead warned of counterfeit versions of its HIV drugs Biktarvy (bictegravir, emtricitabine & tenofovir) and Descovy (emtricitabine and tenofovir) in circulation.